Foley Mark J

Glaukos Corporation · Director

Foley Mark J is listed in public filings as director. This Foley Mark J insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Glaukos Corporation (GKOS), and Revance Therapeutics, Inc. - Common Stock (RVNC). Investors use Foley Mark J's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Glaukos CorporationGKOS--60.3k sharesGrant / ExerciseMay 28, 2026Disclosure amount unavailable1.9k shares----
Glaukos CorporationGKOS$160k3k sharesGrant / ExerciseMay 28, 2026$160.0K3k shares$53.57--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Glaukos CorporationGKOS--58.4k sharesGrant / ExerciseJan 2, 2026Disclosure amount unavailable1.2k shares----
Glaukos CorporationGKOS$299k3.1k sharesGrant / ExerciseMay 29, 2025$298.7K3.1k shares$94.87--
Glaukos CorporationGKOS--57.2k sharesGrant / ExerciseMay 29, 2025Disclosure amount unavailable2.1k shares----
Glaukos CorporationGKOS$6.5M54.2k sharesSellFeb 26, 2025$2.5M20.7k shares$120.72--
Glaukos CorporationGKOS$025k sharesGrant / ExerciseFeb 26, 2025$800.0K25k shares$32.00--
Glaukos CorporationGKOS$015k sharesGrant / ExerciseFeb 26, 2025$370.4K15k shares$24.69--
Revance Therapeutics, Inc. - Common StockRVNC--84.7k sharesOtherFeb 6, 2025Disclosure amount unavailable84.7k shares----
Revance Therapeutics, Inc. - Common StockRVNC--84.7k sharesGrant / ExerciseFeb 6, 2025Disclosure amount unavailable84.7k shares----
Revance Therapeutics, Inc. - Common StockRVNC$102k27.9k sharesOtherFeb 4, 2025$3.6M996.9k shares$3.65--
Revance Therapeutics, Inc. - Common StockRVNC$0110.9k sharesOtherFeb 4, 2025$404.8K110.9k shares$3.65--
Revance Therapeutics, Inc. - Common StockRVNC--1M sharesGrant / ExerciseFeb 3, 2025Disclosure amount unavailable27.9k shares----
Glaukos CorporationGKOS--35.8k sharesGrant / ExerciseJan 2, 2025Disclosure amount unavailable864 shares----
Revance Therapeutics, Inc. - Common StockRVNC$2.2M996.9k sharesGrant / ExerciseDec 31, 2024$2.2K1k shares$2.18--
Revance Therapeutics, Inc. - Common StockRVNC$2.2M995.9k sharesGrant / ExerciseJun 30, 2024$2.2K1k shares$2.18--